BUSINESS DESCRIPTION: One2Touch provides covers for smartphones using Near Field Communication (NFC). The company wants to apply this technology for continuous communication on Machine-to-Machine and IoT platforms, as well as the embedded hardware/software to allow these devices to interact. Additionally, One2Touch is the first company in the world to offer wireless keyboards for smartphones. These “smart” covers have keyboards and/or display attached to them and can be used for work, gaming and more.
BUSINESS DESCRIPTION: Icefresh has developed a patent-pending defrosting technology that can change the supply chain for high-value proteins and seafood in particular. With Icefresh technology the products are deepfrozen and shipped by sea instead of air. When defrosted in the market, the seafood is as fresh as it was when harvested at a cost substantially lower than traditional airfreight and with an environmental footprint that is significantly lower. Icefresh is currently fully operational selling high-end salmon and other seafood products in China.
BUSINESS DESCRIPTION: Hammertech offers a low-cost and robust water meter for multiphase oil&gas flow. The low cost allows the industry to install the meter on a per well basis. Thereby, real-time monitoring of the water production in each well is obtained. The meter has several advantages: No flow restrictions (full pipe diameter), non nuclear and no PVT data. Maintenance and calibration are reduced to a minimum.
BUSINESS DESCRIPTION: BerGenBio AS is a biotech company built on proprietary Screening technology used for the research and pre-clinical development of novel drug targets, associated biomarkers and first in class therapeutics for the treatment of cancer, with lead programs against metastatic drug resistant solid tumors, EMT and drug resistance. BerGenBio’s is driven by a powerful technology platform called CellSelect that provides greater biological insight to the role and function of targets and illustrates therapeutic benefit through regulated dose response therapeutically mimetic studies of target inhibition and translational preclinical modeling.